Cargando…

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States

BACKGROUND: No consensus exists on screening to detect the estimated 2 million Americans unaware of their chronic hepatitis C infections. Advisory groups differ, recommending birth-cohort screening for baby boomers, screening only high-risk individuals, or no screening. We assessed one-time risk ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shan, Cipriano, Lauren E., Holodniy, Mark, Goldhaber-Fiebert, Jeremy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606430/ https://www.ncbi.nlm.nih.gov/pubmed/23533595 http://dx.doi.org/10.1371/journal.pone.0058975

Ejemplares similares

Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2023)

Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
por: Cipriano, Lauren E., et al.
Publicado: (2018)

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
por: Liu, Shan, et al.
Publicado: (2011)

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
por: Lin, Eugene, et al.
Publicado: (2018)

Estimating the cost of cervical cancer screening in five developing countries
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2006)

Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in Non-VA and VA Populations
por: Liu, Shan, et al.
Publicado: (2016)

Patterns of heavy drinking behaviour over age and birth cohorts among Chinese men: a Markov model
por: Lee, Kyueun, et al.
Publicado: (2021)

Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis
por: Bernard, Cora L., et al.
Publicado: (2017)

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2007)

Estimates of Quality-Adjusted Life-Year Loss for Injuries in the United States
por: Raich, William, et al.
Publicado: (2022)

Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)

The costs of reducing loss to follow-up in South African cervical cancer screening
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2005)

Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis
por: Claypool, Anneke L., et al.
Publicado: (2021)

Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
por: Cipriano, Lauren E., et al.
Publicado: (2012)

Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians
por: Mohan, V., et al.
Publicado: (2011)

The Cost of Home Birth in the United States
por: Anderson, David A., et al.
Publicado: (2021)

Quantifying demographic and socioeconomic transitions for computational epidemiology: an open-source modeling approach applied to India
por: Basu, Sanjay, et al.
Publicado: (2015)

Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis
por: Winetsky, Daniel E., et al.
Publicado: (2012)

Program Spending to Increase Adherence: South African Cervical Cancer Screening
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2009)

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis
por: Rens, Neil E, et al.
Publicado: (2020)

Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
por: Tisdale, Rebecca L., et al.
Publicado: (2021)

Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
por: Tatar, Moosa, et al.
Publicado: (2020)

Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic
por: Suen, Sze-chuan, et al.
Publicado: (2014)

Tuberculosis treatment discontinuation and symptom persistence: an observational study of Bihar, India’s public care system covering >100,000,000 inhabitants
por: Babiarz, Kimberly S, et al.
Publicado: (2014)

Low-flow nasal cannula oxygen and potential nosocomial spread of COVID-19
por: Goldhaber-Fiebert, Sara N., et al.
Publicado: (2020)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Diabetes, Its Treatment, and Catastrophic Medical Spending in 35 Developing Countries
por: Smith-Spangler, Crystal M., et al.
Publicado: (2012)

Mapping Inequality in SARS-CoV-2 Household Exposure and Transmission Risk in the USA
por: Reitsma, Marissa B., et al.
Publicado: (2021)

Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity
por: Reitsma, Marissa B., et al.
Publicado: (2021)

Providers' knowledge of diagnosis and treatment of tuberculosis using vignettes: evidence from rural Bihar, India
por: Mohanan, Manoj, et al.
Publicado: (2016)

Comparison of Strategies for Typhoid Conjugate Vaccine Introduction in India: A Cost-Effectiveness Modeling Study
por: Ryckman, Theresa, et al.
Publicado: (2021)

Hepatitis A Hospitalization Costs, United States, 2017
por: Hofmeister, Megan G., et al.
Publicado: (2020)

A95 ASSESSMENT OF BIRTH COHORT SCREENING OF CHRONIC HEPATITIS C IN COLORECTAL CANCER SCREENING PATIENTS IN BRITISH COLUMBIA
por: Kaviani, R, et al.
Publicado: (2023)

Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997
por: Chen, Brian K, et al.
Publicado: (2011)

Which patients receive surgery in for-profit and non-profit hospitals in a universal health system? An explorative register-based study in Norway
por: Holom, Geir Hiller, et al.
Publicado: (2018)

The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
por: Day-Storms, Jeremy J., et al.
Publicado: (2021)

Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons
por: Prince, Lea, et al.
Publicado: (2022)

Optimizing Implementation of Hepatitis C Birth-Cohort Screening and Treatment Strategies: Model-Based Projections
por: Li, Yuankun, et al.
Publicado: (2017)

Operative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness Analysis
por: Sceats, Lindsay A., et al.
Publicado: (2019)

Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9tmgppc7m5jine4dj1vd1aq8ir